Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.39 USD | -1.31% | +0.17% | +169.12% |
05-17 | Vera Therapeutics Insider Sold Shares Worth $1,304,435, According to a Recent SEC Filing | MT |
05-10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+169.12% | 2.29B | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Wedbush Lifts Vera Therapeutics' Price Target to $16 From $12, Keeps Neutral Rating